Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus

AIDS Patient Care and STDs

Volumn 27, Issue 5, 2013, Pages 266-271

  Jarrett, Olamide D ^a   Wanke, Christine A ^b,c   Ruthazer, Robin ^b   Bica, Ioana ^d   Isaac, Rita ^e   Knox, Tamsin A ^b,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; POVERTY; PROGNOSIS; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; BODY MASS INDEX; CAUSE OF DEATH; CHOLESTEROL, HDL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; HYPERTENSION; INCIDENCE; INTERVIEWS AS TOPIC; MALE; MASSACHUSETTS; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK FACTORS; TRIGLYCERIDES;

EID: 84877615400     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0402     Document Type: Article

References (31)

1. Adeyemi O, Rezai K, Bahk M, Badri S, Thomas-Gossain N. Metabolic syndrome in older HIV-infected patients: Data from the CORE50 cohort. AIDS Patient Care STDS 2008;22:941-945.
2. Alencastro PR, Fuchs SC, Wolff FH, Ikeda ML, Brandao AB, Barcellos NT. Independent predictors of metabolic syndrome in HIV-infected patients. AIDS Patient Care STDS 2011;25:627-634.
3. Alvarez C, Salazar R, Galindez J, et al. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America. Braz J Infect Dis 2010;14:256-263.
4. Freitas P, Carvalho D, Souto S, et al. Impact of lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients. BMC Infect Dis 2011;11:246.
5. Jacobson DL, Tang AM, Spiegelman D, et al. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey). JAIDS 2006;43:458-466. (Pubitemid 44737105)
6. Mondy K, Overton ET, Grubb J, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis 2007;44:726-734.
7. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004;173:309-314. (Pubitemid 38469801)
8. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-414. (Pubitemid 46135879)
9. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, San Antonio Heart S. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004;110:1251-1257. (Pubitemid 39202341)
10. Jones CY, Wilson IB, Greenberg AS, et al. Insulin resistance in HIV-infected men and women in the nutrition for healthy living cohort. JAIDS 2005;40:202-211. (Pubitemid 41395720)
11. Katzmarzyk PT, Church TS, Blair SN. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Int Med 2004;164:1092-1097. (Pubitemid 38668988)
12. Levantesi G, Macchia A, Marfisi R, et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 2005;46:277-283. (Pubitemid 40966856)
13. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245-1250. (Pubitemid 39202340)
14. Badiou S, Thiebaut R, Aurillac-Lavignolle V, et al. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients. J Infect 2008;57:47-54.
15. Mangili A, Jacobson DL, Gerrior J, Polak JF, Gorbach SL, Wanke CA. Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV. Clin Infect Dis 2007;44:1368-1374. (Pubitemid 46717301)
16. Bernal E, Marin I, Munoz A, Saban J, Vicente-Vera T, Cano A. High prevalence of subclinical atherosclerotic disease in Spanish HIV-infected patients with low cardiovascular risk. AIDS Patient Care STDS 2011;25:269-272.
17. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987;166:1-8. (Pubitemid 17095867)
18. Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol 2000;95:3482-3489.
19. Grundy SM, Brewer HB, Jr., Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109: 433-438. (Pubitemid 38133916)
20. Bonfanti P, Giannattasio C, Ricci E, et al. HIV and metabolic syndrome: A comparison with the general population. JAIDS 2007;45:426-431. (Pubitemid 47057669)
21. Palacios R, Santos J, Gonzalez M, Ruiz J, Marquez M. Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: Prospective analysis at 48 weeks of highly active antiretroviral therapy. Intl J STD AIDS 2007;18:184-187. (Pubitemid 351739049)
22. Squillace N, Zona S, Stentarelli C, et al. Detectable HIV viral load is associated with metabolic syndrome. JAIDS 2009;52: 459-464.
23. Grunfeld C, Feingold KR. The role of the cytokines, interferon alpha and tumor necrosis factor in the hypertriglyceridemia and wasting of AIDs. J Nutrit 1992;122:749-753.
24. Shor-Posner G, Basit A, Lu Y, et al. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med 1993;94:515-519. (Pubitemid 23142967)
25. Chaudhary M, Kashyap B, Gautam H, Saini S, Bhalla P. Role of C-reactive protein in HIV infection: A pilot study. Viral Immunol 2008;21:263-266. (Pubitemid 351873362)
26. Feldman JG, Goldwasser P, Holman S, DeHovitz J, Minkoff H. C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. JAIDS 2003;32:210-214. (Pubitemid 36222724)
27. Marsik C, Kazemi-Shirazi L, Schickbauer T, et al. C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem 2008;54:343-349. (Pubitemid 351302621)
28. Falasca K, Ucciferri C, Manzoli L, et al. Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. Intl J Immunopathol Pharmacol 2007;20:519-527. (Pubitemid 47531055)
29. Rubsamen-Waigmann H, Schroder B, Biesert L, et al. Markers for HIV-disease progression in untreated patients and patients receiving AZT: Evaluation of viral activity, AZT resistance, serum cholesterol, beta 2-microglobulin, CD4 + cell counts, and HIV antigen. Infection 1991;19:S77-82.
30. Thiebaut R, Dabis F, Malvy D, Jacqmin-Gadda H, Mercie P, ValentinVd. Serum triglycerides, HIV infection, and highly active antiretroviral therapy, Aquitaine Cohort, France, 1996 to 1998. Groupe d'Epidemiologie Clinique du Sida en Aquitaine (GECSA). JAIDS 2000;23:261-265. (Pubitemid 30331245)
31. Bonfanti P, De Socio GL, Marconi P, et al. Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study. Curr HIV Res 2010;8:165-171.